Results 1 to 10 of about 35,905 (251)

“Stapling” scFv for multispecific biotherapeutics of superior properties

open access: yesMAbs, 2023
Single-chain fragment variable (scFv) domains play an important role in antibody-based therapeutic modalities, such as bispecifics, multispecifics and chimeric antigen receptor T cells or natural killer cells.
Lauren E Boucher   +2 more
exaly   +4 more sources

Development of a recombinant biosimilar single-chain variable fragment antibody targeting human estrogen receptor α36 [PDF]

open access: yesResearch in Pharmaceutical Sciences
Background and purpose: The estrogen receptor alpha-36 (ER-α36) is an alternative splice variant of classical ER-α66 and is abundantly present in both ER-α66-positive and ER-α66-negative breast tumor cells.
Soodabeh Shafiee   +7 more
doaj   +2 more sources

Development of a single-chain fragment variable fused-mutant HALT-1 recombinant immunotoxin against G12V mutated KRAS colorectal cancer cells [PDF]

open access: yesPeerJ, 2021
Background KRAS oncogenes harboring codon G12 and G13 substitutions are considered gatekeeper mutations which drive oncogenesis in many cancers.
Michelle Yee Mun Teo   +6 more
doaj   +2 more sources

Recombinant expression of monovalent and bivalent anti-TNT-antibodies: Evaluation of different expression systems [PDF]

open access: yesJournal of the Serbian Chemical Society, 2008
Monoclonal 11B3 anti-TNT (trinitrotoluene) antibody was expressed as a monovalent and bivalent form using different prokaryotic and eukaryotic expression systems.
Simonović Mladen   +3 more
doaj   +1 more source

Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

open access: yesOncoImmunology, 2022
Retargeting of T lymphocytes toward cancer cells by bispecific antibodies has demonstrated its therapeutic potential, with one such antibody approved for the treatment of acute lymphoblastic leukemia (blinatumomab) and several other in clinical trials ...
Antonio Tapia-Galisteo   +15 more
doaj   +1 more source

Development of alkaline phosphatase-scFv and its use for one-step enzyme-linked immunosorbent assay for His-tagged protein detection

open access: yesOpen Life Sciences, 2022
A histidine (His)-tag is composed of six His residues and typically exerts little influence on the structure and solubility of expressed recombinant fusion proteins.
He Shuzhen   +10 more
doaj   +1 more source

­­­Successful Application of Whole Cell Panning for Isolation of Phage Antibody Fragments Specific to Differentiated Gastric Cancer Cells [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2019
Purpose: Generation of antibodies which potentially discriminate between malignant and healthy cells is an important prerequisite for early diagnosis and treatment of gastric cancer (GC).
Sepideh Nikfarjam   +5 more
doaj   +1 more source

Novel Plantibodies Show Promise to Protect Citrus from Greening Disease

open access: yesJournal of the American Society for Horticultural Science, 2021
Candidatus Liberibacter asiaticus (CLas), the bacteria responsible for citrus greening disease [huanglongbing (HLB)], has become a worldwide threat to citrus (Citrus sp.) production.
Joseph Krystel   +3 more
doaj   +1 more source

Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines

open access: yesPharmaceutics, 2022
Following our previous study on the development of EGFR-targeted nanomedicine (NM-scFv) for the active delivery of siRNA in EGFR-positive cancers, this study focuses on the development and the quality control of a radiolabeling method to track it in in ...
Phuoc-Vinh Nguyen   +7 more
doaj   +1 more source

Antibody-Mediated Resistance to Rhizomania Disease in Sugar Beet Hairy Roots

open access: yesThe Plant Pathology Journal, 2019
Agrobacterium rhizogenes–mediated transformation of sugar beet hairy roots expressing single-chain variable fragment (scFv) was exploited to evaluate the efficacy of four antibody-based constructs for interfering with the Beet necrotic yellow vein virus ...
M. Jafarzade   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy